Dolphin Medical Services Limited (BOM: 526504)
India
· Delayed Price · Currency is INR 3.010
-0.140 (-4.44%)
At close: Dec 23, 2024
Dolphin Medical Services Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Operating Revenue | 7.36 | 6.79 | 6.11 | 5.2 | 4.73 | 1.82 | Upgrade
|
| Other Revenue | 0.37 | 0.37 | 0.37 | 0.37 | 55.52 | 0.47 | Upgrade
|
| Revenue | 7.73 | 7.15 | 6.48 | 5.57 | 60.25 | 2.3 | Upgrade
|
| Revenue Growth (YoY) | 15.41% | 10.39% | 16.31% | -90.75% | 2524.98% | 92.85% | Upgrade
|
| Cost of Revenue | 2.73 | 2.78 | 2.42 | 2.21 | 2.19 | 1.06 | Upgrade
|
| Gross Profit | 5 | 4.38 | 4.06 | 3.36 | 58.06 | 1.23 | Upgrade
|
| Selling, General & Admin | 1.19 | 1.19 | 1.11 | 1.11 | 1.13 | 0.62 | Upgrade
|
| Other Operating Expenses | 4.22 | 3.59 | 3.4 | 3.29 | 4.02 | 3.6 | Upgrade
|
| Operating Expenses | 5.83 | 5.24 | 5.14 | 5.03 | 5.78 | 4.83 | Upgrade
|
| Operating Income | -0.83 | -0.87 | -1.08 | -1.67 | 52.28 | -3.6 | Upgrade
|
| Interest Expense | -0.1 | -0.1 | -0.09 | -0.09 | -0.1 | -0.04 | Upgrade
|
| EBT Excluding Unusual Items | -0.92 | -0.96 | -1.18 | -1.76 | 52.19 | -3.64 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -55.14 | - | Upgrade
|
| Pretax Income | -0.92 | -0.96 | -1.18 | -1.76 | -2.96 | -3.64 | Upgrade
|
| Income Tax Expense | 0.08 | 0.08 | 0.07 | 0.11 | 0.17 | 0.21 | Upgrade
|
| Net Income | -1 | -1.04 | -1.25 | -1.87 | -3.12 | -3.85 | Upgrade
|
| Net Income to Common | -1 | -1.04 | -1.25 | -1.87 | -3.12 | -3.85 | Upgrade
|
| Shares Outstanding (Basic) | 16 | 15 | 16 | 16 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 16 | 15 | 16 | 16 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | 2.20% | -4.60% | -0.32% | 5.08% | 0.38% | -1.25% | Upgrade
|
| EPS (Basic) | -0.06 | -0.07 | -0.08 | -0.12 | -0.21 | -0.26 | Upgrade
|
| EPS (Diluted) | -0.06 | -0.07 | -0.08 | -0.12 | -0.21 | -0.26 | Upgrade
|
| Free Cash Flow | -0.9 | -0.45 | -0.69 | -0.99 | 2.72 | -1.69 | Upgrade
|
| Free Cash Flow Per Share | -0.06 | -0.03 | -0.04 | -0.06 | 0.18 | -0.11 | Upgrade
|
| Gross Margin | 64.70% | 61.16% | 62.65% | 60.34% | 96.37% | 53.79% | Upgrade
|
| Operating Margin | -10.72% | -12.14% | -16.72% | -29.93% | 86.78% | -156.78% | Upgrade
|
| Profit Margin | -12.94% | -14.54% | -19.23% | -33.65% | -5.18% | -167.79% | Upgrade
|
| Free Cash Flow Margin | -11.61% | -6.29% | -10.66% | -17.71% | 4.52% | -73.68% | Upgrade
|
| EBITDA | -0.51 | -0.4 | -0.46 | -1.04 | 52.92 | -2.98 | Upgrade
|
| EBITDA Margin | -6.59% | -5.64% | -7.04% | -18.68% | 87.83% | -129.89% | Upgrade
|
| D&A For EBITDA | 0.32 | 0.47 | 0.63 | 0.63 | 0.64 | 0.62 | Upgrade
|
| EBIT | -0.83 | -0.87 | -1.08 | -1.67 | 52.28 | -3.6 | Upgrade
|
| EBIT Margin | -10.72% | -12.14% | -16.72% | -29.93% | 86.78% | -156.78% | Upgrade
|
| Revenue as Reported | 7.73 | 7.15 | 6.48 | 5.57 | 60.25 | 2.3 | Upgrade
|
| Advertising Expenses | - | 0.08 | 0.08 | 0.08 | 0.07 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.